Literature DB >> 3715933

Acute myocardial and plasma catecholamine changes in experimental stroke.

V C Hachinski, K E Smith, M D Silver, C J Gibson, J Ciriello.   

Abstract

Focal cerebral ischemia in humans increases the incidence of cardiac arrhythmias, and serum cardiac enzyme and plasma norepinephrine levels. In addition, systemic administration of catecholamines causes myocardial damage. This suggests that cerebral ischemia may cause myocardial damage as a consequence of elevated plasma norepinephrine levels. Therefore, experiments were done in 23 chloralosed, paralyzed and artificially ventilated cats to investigate the effects of occluding (n = 17) or sham-occluding (n = 6) the left middle cerebral artery on the myocardium and on circulating levels of plasma catecholamines. After occlusion of the middle cerebral artery for 12-22 hr, 41% (7/17) of the hearts had either acute myocardial necrosis (3/7), focal hemorrhage (3/7), or both (1/7). In animals with acute myocardial damage the levels of plasma norepinephrine and epinephrine were significantly increased compared to pre- middle cerebral artery occlusion values (+46 +/- 18% and +142 +/- 45%, respectively). As well, in cats with acute myocardial damage, changes from initial levels of plasma norepinephrine and epinephrine were significantly increased over those of experimental cats without acute myocardial damage. In animals which did not have acute myocardial damage (10/17) the circulating plasma levels of catecholamines were not significantly different from pre-occlusion values. Similarly, sham occlusion did not alter plasma catecholamine levels. These data demonstrate that a percentage of animals subjected to middle cerebral artery occlusion have myocardial damage and an increase in plasma concentration of norepinephrine and epinephrine. This suggests that a rise in plasma catecholamine levels, due to increased sympathetic activity after middle cerebral artery occlusion, may cause myocardial damage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3715933     DOI: 10.1161/01.str.17.3.387

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

1.  Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage.

Authors:  Avinash Kothavale; Nader M Banki; Alexander Kopelnik; Sirisha Yarlagadda; Michael T Lawton; Nerissa Ko; Wade S Smith; Barbara Drew; Elyse Foster; Jonathan G Zaroff
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage.

Authors:  Jonathan G Zaroff; Ludmila Pawlikowska; Jacob C Miss; Sirisha Yarlagadda; Connie Ha; Achal Achrol; Pui-Yan Kwok; Charles E McCulloch; Michael T Lawton; Nerissa Ko; Wade Smith; William L Young
Journal:  Stroke       Date:  2006-05-25       Impact factor: 7.914

Review 3.  Exosome-mediated amplification of endogenous brain repair mechanisms and brain and systemic organ interaction in modulating neurological outcome after stroke.

Authors:  Poornima Venkat; Jieli Chen; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2018-06-11       Impact factor: 6.200

4.  Relationship of Troponin T and Age- and Sex-Adjusted BNP Elevation Following Subarachnoid Hemorrhage with 30-Day Mortality.

Authors:  Katherine M Duello; Jay P Nagel; Colleen S Thomas; Joseph L Blackshear; William D Freeman
Journal:  Neurocrit Care       Date:  2015-08       Impact factor: 3.210

5.  Is β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage?

Authors:  Jayantee Kalita; Usha Kant Misra; Bishwanath Kumar
Journal:  Neurol Sci       Date:  2012-10-09       Impact factor: 3.307

6.  Cardiovascular predictors of long-term outcomes after non-traumatic subarachnoid hemorrhage.

Authors:  Jonathan G Zaroff; Jonathan Leong; Helen Kim; William L Young; Sean P Cullen; Vivek A Rao; Michael Sorel; Charles P Quesenberry; Steve Sidney
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

7.  Primary intracranial hemorrhage presenting as acute myocardial infarction: a contraindication to thrombolytic therapy.

Authors:  A D Kitching; M Bernstein; B F O'Kelly
Journal:  CMAJ       Date:  1994-02-15       Impact factor: 8.262

8.  Troponin elevation predicts critical care needs and in-hospital mortality after thrombolysis in white but not black stroke patients.

Authors:  Roland Faigle; Elisabeth B Marsh; Rafael H Llinas; Victor C Urrutia; Rebecca F Gottesman
Journal:  J Crit Care       Date:  2015-12-02       Impact factor: 3.425

9.  Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors.

Authors:  K K Khush; L Pawlikowska; R L Menza; B A Goldstein; V Hayden; J Nguyen; H Kim; A Poon; A Sapru; M A Matthay; P Y Kwok; W L Young; L A Baxter-Lowe; J G Zaroff
Journal:  Am J Transplant       Date:  2012-09-20       Impact factor: 8.086

10.  Statins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation.

Authors:  Woo-Yang Kim; Eugene A Gonsiorek; Chris Barnhart; Monika A Davare; Abby J Engebose; Holly Lauridsen; Donald Bruun; Adam Lesiak; Gary Wayman; Robert Bucelli; Dennis Higgins; Pamela J Lein
Journal:  J Neurochem       Date:  2009-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.